Cancer Research Technology Selects the Labcyte Inc. Access™ Laboratory Workstation to Prepare Assay-Ready Microplates for Cell-Based Screening

Published: Jun 19, 2012

LONDON--(BUSINESS WIRE)--Cancer Research Technology (CRT), the cancer-focused technology development and commercialization arm of Cancer Research UK, announced today the implementation of the Labcyte Access workstation to automate the production of assay-ready plates to be used in a high-throughput cell based screening program.

Back to news